0001618835-18-000046.txt : 20180703
0001618835-18-000046.hdr.sgml : 20180703
20180703165604
ACCESSION NUMBER: 0001618835-18-000046
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lynch Thomas G
CENTRAL INDEX KEY: 0001360000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36754
FILM NUMBER: 18938158
MAIL ADDRESS:
STREET 1: C/O EVOFEM BIOSCIENCES, INC.
STREET 2: 12400 HIGH BLUFF DRIVE, SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evofem Biosciences, Inc.
CENTRAL INDEX KEY: 0001618835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208527075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 550-1900
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Neothetics, Inc.
DATE OF NAME CHANGE: 20140905
4
1
wf-form4_153065134806235.xml
FORM 4
X0306
4
2018-07-02
0
0001618835
Evofem Biosciences, Inc.
EVFM
0001360000
Lynch Thomas G
C/O EVOFEM BIOSCIENCES, INC.
12400 HIGH BLUFF DRIVE, SUITE 600
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2018-07-02
4
M
0
75000
0
A
75000
D
Restricted Stock Units
2018-07-02
4
A
0
75000
0
A
Common Stock
75000.0
75000
D
Restricted Stock Units
2018-07-02
4
M
0
75000
0
D
Common Stock
75000.0
0
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units were granted in consideration for certain consulting services provided to the Issuer in connection with the consulting agreement between Mr. Lynch and the Issuer dated April 1, 2016.
The restricted stock units vested in full on July 2, 2018.
The restricted stock units were granted subject to a 90-day lock-up agreement pursuant to an Underwriting Agreement, the form of which was filed with a Registration Statement on Form S-1 as filed with the SEC on May 16, 2018. During the 90-day lock-up period commencing from May 22, 2018, the Reporting Person may not sell any vested shares.
/s/ Justin J. File, attorney-in-fact
2018-07-03